Zurück zu den Rankings

MetLife Inc (MET)

Fair bewertet
Financial ServicesInsurance - LifeUnited States

Fundamental

46

Kurs

$92.36

Marktkapitalisierung

$60.89B

Teil 1 · Was das Unternehmen wert ist

Übersicht

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 19. September 2026 with claude-haiku-4-5 — shared with all users

P/E: 10.3Score: 63Market cap: $40.05B

Prudential bids against MetLife for the same large-employer group life and disability contracts and for the same pension risk transfer and institutional retirement mandates in the United States, often splitting the biggest deals between the two.

P/E: 20.4Score: 55Market cap: $14.42B

Unum sells the same workplace benefits package — group disability, group life and voluntary coverages — to the same US employers and brokers that MetLife's Group Benefits segment serves.

P/E: 7.9Score: 83Market cap: $34.14B

The Hartford's Employee Benefits arm competes head-on with MetLife for group life, disability and absence-management programmes at US employers of every size.

P/E: 12.1Score: 65Market cap: $56.93B

Aflac competes with MetLife in the same two markets that matter most to it: voluntary supplemental benefits sold at the US workplace, and life and health policies sold to Japanese households.

P/E: 16.1Score: 59Market cap: $24.66B

Principal chases the same small and mid-sized employers for group benefits and workplace retirement plans, and competes with MetLife Investment Management for institutional asset mandates.

Lincoln National CorporationLNC

Lincoln's Group Protection unit and its individual life and annuity lines target the same US employers and retail savers that MetLife pursues.

Bilanz & Liquidität

Umsatz

$2.68B

Letzte 12 Monate (bis 30.6.2026)

Nettogewinn

$3.63B

Letzte 12 Monate (bis 30.6.2026)

Freier Cashflow

-

Gesamtes Eigenkapital

$28.40B

Gesamtverbindlichkeiten

$716.25B

Current Ratio

0.19

Zinsdeckungsgrad

8.48

Schulden/EBITDA

2.43

Gewinn je Aktie

Umsatz & Nettogewinn

Freier Cashflow

Ertragsaufschlüsselung

Historische Aufstellung

Margen im Zeitverlauf

Verschuldung im Zeitverlauf

Wie schwer die Schulden wiegen

Wachstumsraster

Wachstum — Umsatz

Innerer-Wert-Schätzung

VersicherungFair bewertet

Innerer Wert

$78.06

Aktueller Kurs

$92.36

Sicherheitsmarge

-18.3%

Innerer-Wert-Spanne

$56.93 - $99.20

Streubreite zwischen den verwendeten Bewertungsmethoden, kein statistisch kalibriertes Konfidenzintervall.

Bewertungsmethoden

Kursziel der Analysten:$105.75
Diskontierter Cashflow (DCF):Nicht anwendbar für diesen Unternehmenstyp
Gewinnmultiplikator (P/E):$46.32
Graham-Wachstumsformel:Nicht anwendbar für diesen Unternehmenstyp
Ertragskraftwert (EPV):Nicht anwendbar für diesen Unternehmenstyp
Gerechtfertigtes P/B:$79.02
Dividendendiskontierung (Gordon):$53.74
P/FFO, Funds from Operations:Nicht anwendbar für diesen Unternehmenstyp
Gewinn im Zyklusmittel:Nicht anwendbar für diesen Unternehmenstyp
Umsatzmultiplikator:Nicht anwendbar für diesen Unternehmenstyp
Analystenkonsens:Kaufen (17B / 7H / 0S)
Letzte Gewinnüberraschung:+4.93%

Bewertungskennzahlen

P/E-Verhältnis

18.00

ROE

11.9%

P/B-Verhältnis

2.18

P/FCF

-

Bruttomarge

-

ROIC

-

Rentabilitäts-Radar

Wertschöpfung (Wettbewerbsvorteil)

ROIC

-

WACC

7.9%

ROIC − WACC

-

Fundamentalanalyse-Kriterien

Bestanden (11)

  • Price CAGR 7.30%
  • P/B Ratio 2.18
  • Operating Margin 245.0%
  • Interest Coverage
  • Debt/EBITDA
  • Low reliance on intangibles
  • ROE 12.9%
  • Analyst Consensus 71% Buy
  • Earnings Surprise avg 5.2%
  • Earnings Quality (OCF/NI) 4.29
  • Share Dilution -3.7%

Nicht bestanden (9)

  • EPS shows upward trend
  • EPS CAGR -0.84%
  • Debt/Equity ratio
  • Return on Tangible Assets
  • Price below Graham Number
  • DCF valuation (Unknown)
  • Revenue Growth 5Y 2.6%
  • Net Margin Trend 135.3% vs 184.4%
  • Piotroski F-Score 4/9

Nicht verfügbar (8)

  • ROIC NaN%
  • Gross Margin NaN%
  • P/FCF NaN
  • Dividend Payout NaN%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-Score

4/9

Gemischte Signale: Einige Bereiche bedürfen Aufmerksamkeit

score
criteria

Gewinnqualität

4.29

Hohe Qualität: Gewinne durch Cashflow gedeckt

Aktienverwässerung

-3.7%

Aktienrückkäufe. Aktionärsfreundlich

Institutionelle Beteiligungen

Unternehmensführung

Führungsteam

NamePositionAlter
Mr. Michel Abbas KhalafCEO, President & Director-
Mr. Bill PappasExecutive VP and Head of Global Technology & Operations55
Ms. Marlene Beverly DebelExecutive VP, Chief Risk Officer & Head of Insurance Investments58
Mr. Ramy TadrosRegional President of U.S. Business & Head of MetLife Holdings49
Mr. John Arthur HallSenior VP, Head of Investor Relations & Executive VP and Treasurer-
Ms. Monica M. CurtisExecutive VP, Chief Legal Officer & Head of Government Relations42
Ms. Jane SlusarkChief Communications Officer-
Mr. Michael RobertsExecutive VP & Chief Marketing Officer-
Ms. Shurawl SibbliesExecutive VP & Chief Human Resources Officer53
Mr. Randy StramSenior Vice President of Group Benefits-

Prüfungsrisiko

4

Vorstandsrisiko

3

Vergütungsrisiko

1

Aktionärsrechterisiko

9

Teil 2 · Der Preis und der Einstiegszeitpunkt

Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.

Dokumente

  • Jahresbericht (10-K)

    Ein jährlicher Überblick über das Geschäft, die Finanzergebnisse und die Risiken des Unternehmens.

    Eingereicht am 2026-02-19

    Dokument ansehen
  • Quartalsbericht (10-Q)

    Ein Update zur finanziellen Entwicklung der letzten drei Monate.

    Eingereicht am 2026-08-06

    Dokument ansehen
  • Ad-hoc-Meldung (8-K)

    Eine Mitteilung über ein wichtiges Ereignis, etwa einen Führungswechsel oder eine bedeutende Ankündigung.

    Eingereicht am 2026-09-24

    Dokument ansehen

via SEC EDGAR

Ertragshistorie

via SEC EDGAR

Latest News

Recent headlines for MET, sourced from Markets Gazette.

  • 8/5/2026POSITIVE
    MetLife’s Earnings Beat Wall Street Expectations

    MetLife Inc. reported second-quarter earnings that exceeded Wall Street's projections, driven by robust underwriting performance and significant volume growth. The company's success is attributed in part to its strategic five-year plan, initiated in late 2024, which appears to be yielding positive results. This earnings beat suggests effective operational management and strategic execution, potentially signaling a favorable outlook for the insurance giant. Investors will be watching for continued momentum and the long-term impact of the company's strategic initiatives.

  • 5/28/2026NEUTRAL
    MetLife Clashes With Ares Over Struggling Football Investment

    MetLife Inc. is reportedly in a dispute with Ares Management regarding the restructuring of Eagle Football, a holding company with stakes in several football clubs, notably Olympique Lyonnais. The disagreement centers on the financial strategy and future direction of the football investment group. While the specific details of the clash are not fully disclosed, such disputes can introduce uncertainty for investors in the involved entities. The outcome could impact the valuation and operational stability of the football assets.

  • 5/6/2026POSITIVE
    MetLife’s Improved PE Returns Lift Earnings Above Expectations

    MetLife Inc. reported first-quarter earnings that exceeded Wall Street consensus, primarily driven by enhanced returns from its private equity investments. The insurer's ability to leverage its private equity portfolio for higher gains signals effective asset management and a robust strategy in alternative investments. This performance suggests a positive outlook for MetLife's financial health and could be interpreted by investors as a sign of strong operational execution and potential for future growth, especially in its alternative asset classes.

  • 2/24/2026NEUTRAL
    Polymarket users favor Meteora in bets over ZachXBT crypto takedown

    Polymarket users have wagered over $7 million on the outcome of the investigation by prominent crypto sleuth ZachXBT, with an announcement expected on Thursday. The betting patterns indicate a preference for Meteora, suggesting many investors believe the DeFi protocol will navigate the inquiry without severe repercussions. This speculative activity underscores the high tension and uncertainty surrounding crypto projects under scrutiny, as the market attempts to anticipate the impact of potential 'takedowns'. The impending announcement will be crucial in determining the future direction of the MET token, introducing potential volatility.

via Markets Gazette